Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic drugs with antipruritic potency.

E Weisshaar1, H Gollnick

  • 1Department of Dermatology, Otto-von-Guericke-University, Magdeburg, Germany.

Skin Therapy Letter
|June 15, 2000
PubMed
Summary

Itch relief is limited due to poor understanding of its causes. This review explores systemic drugs and therapies for various itch types, aiming for evidence-based treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Update on the assessment of the impact of occupational contact allergies in case of occupational skin disease no. 5101].

Dermatologie (Heidelberg, Germany)·2026
Same author

Chronic nodular prurigo: Association between comorbidities, itch and quality of life.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Stigmatization and social anxiety in patients with skin diseases].

Dermatologie (Heidelberg, Germany)·2023
Same author

Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Atopic dermatitis and depressive symptoms. Results of the German national AD Registry TREATgermany.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Area of Science:

  • Dermatology
  • Pharmacology
  • Internal Medicine

Background:

  • Itch (pruritus) is a prevalent and distressing symptom in many skin and systemic diseases.
  • Limited understanding of itch pathophysiology hinders the development of effective anti-itch treatments.
  • Current therapies for itch are often empirical, lacking strong evidence-based support.

Purpose of the Study:

  • To review major systemic drugs with antipruritic properties.
  • To provide an overview of different types of pruritus.
  • To discuss potential systemic therapies for various pruritus etiologies.

Main Methods:

  • Literature review of case reports and experimental investigations.
  • Focus on systemic medications with documented antipruritic effects.
  • Categorization of pruritus types and associated systemic treatment options.

Main Results:

  • No specific antipruritic drugs are currently available on the market.
  • Numerous medications show potential antipruritic activity, supported by case reports and studies.
  • A range of systemic therapies can be considered for different pruritus presentations.

Conclusions:

  • Further research into itch pathophysiology is crucial for developing targeted therapies.
  • Systemic drug review and understanding pruritus types can guide evidence-based treatment strategies.
  • Improving anti-itch treatments requires a shift from empirical to evidence-based approaches.

Related Experiment Videos